...
首页> 外文期刊>Annals of surgical oncology >Fra-1 Regulates the?Expression of HMGA1,?Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma
【24h】

Fra-1 Regulates the?Expression of HMGA1,?Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma

机译:FRA-1调节HMGA1的表达,?这与人食管鳞状细胞癌的预后不良有关

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background The expression of Fos-related antigen 1 (Fra-1) affects tumor progression, migration, and invasion. In this study, we identified the genes regulated by Fra-1 in esophageal squamous cell carcinoma (ESCC). Methods We constructed Fra-1 knockdown models via the transfection of small interfering RNA (siRNA) into ESCC cell lines (TE10, TE11). The expression levels of the genes in the knockdown models were analyzed using a microarray and a Biobase Upstream Analysis, while the expression levels of the candidate genes in the primary tumors of surgical specimens obtained from ESCC patients were determined using real-time polymerase chain reaction (PCR) and immunohistochemical staining. The clinicopathological features were then analyzed. Results The Biobase Upstream Analysis showed the high-mobility-group protein-1 (HMGA1) to be a significant gene regulated by Fra-1. Actual binding of Fra-1 to the promotor region of HMGA1 was revealed in subsequent chromatin immunoprecipitation PCR experiments. Patients with a positive HMGA1 expression had a poor prognosis, and a multivariate analysis demonstrated a positive HMGA1 expression to be a significant independent prognostic factor. Conclusion HMGA1 is regulated by Fra-1 in ESCC, and the HMGA1 expression is significantly associated with a poor prognosis in ESCC patients. Downregulation of the HMGA1 expression may become a practical treatment strategy against ESCC in the future. ]]>
机译:摘要背景FOS相关抗原1(FRA-1)的表达影响肿瘤进展,迁移和入侵。在这项研究中,我们鉴定了通过食管鳞状细胞癌(ESCC)的FRA-1调节的基因。方法通过将小干扰RNA(siRNA)转换为ESCC细胞系(TE10,TE11)来构建FRA-1敲低模型。使用微阵列和生物酶上游分析分析敲低模型中基因的表达水平,而使用实时聚合酶链反应测定从ESCC患者获得的外科患者的手术标本的候选基因的表达水平( PCR)和免疫组织化学染色。然后分析临床病理学特征。结果BioBase上游分析显示,高迁移率 - 组蛋白-1(HMGA1)是通过FRA-1调节的重要基因。在随后的染色质免疫沉淀PCR实验中揭示了FRA-1至HMGA1的启动区的实际结合。患有阳性HMGA1表达的患者的预后差,多元分析表现出阳性HMGA1表达,是具有重要的独立预后因子。结论HMGA1受ESCC的FRA-1调节,HMGA1表达与ESCC患者的预后差显着相关。 HMGA1表达的下调可能成为未来ESCC的实际处理策略。 ]]>

著录项

  • 来源
    《Annals of surgical oncology》 |2017年第11期|共10页
  • 作者单位

    Department of Frontier Surgery Graduate School of Medicine Chiba University;

    Department of Frontier Surgery Graduate School of Medicine Chiba University;

    Department of Frontier Surgery Graduate School of Medicine Chiba University;

    Department of Frontier Surgery Graduate School of Medicine Chiba University;

    Department of Frontier Surgery Graduate School of Medicine Chiba University;

    Department of Frontier Surgery Graduate School of Medicine Chiba University;

    Department of Frontier Surgery Graduate School of Medicine Chiba University;

    Department of Frontier Surgery Graduate School of Medicine Chiba University;

    Department of Frontier Surgery Graduate School of Medicine Chiba University;

    Department of Frontier Surgery Graduate School of Medicine Chiba University;

    Department of Frontier Surgery Graduate School of Medicine Chiba University;

    Department of Frontier Surgery Graduate School of Medicine Chiba University;

    Department of Frontier Surgery Graduate School of Medicine Chiba University;

    Department of Frontier Surgery Graduate School of Medicine Chiba University;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 外科学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号